Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Quality assurance of TomoDirect treatment plans using I'mRT MatriXX.
Effective connectivity between superior temporal gyrus and Heschl's gyrus during white noise listening: linear versus non-linear models.
Pelvic lipomatosis: US and CT diagnosis.
Related Experiment Video
Updated: Jun 1, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Radioimmunotherapy: a brief overview.
1Department of Nuclear Medicine and PET, Singapore General Hospital, Singapore.
Radioimmunotherapy (RIT) is a promising cancer treatment, especially for non-Hodgkin's lymphoma, utilizing targeted antibodies and radiation. Ongoing research explores new applications in blood cancers, solid tumors, and innovative treatment protocols.
Area of Science:
- Oncology
- Nuclear Medicine
- Biotechnology
Background:
- Radioimmunotherapy (RIT) leverages advances in molecular and cellular biology for cancer treatment.
- RIT has demonstrated clinical efficacy, particularly in treating non-Hodgkin's lymphomas.
Purpose of the Study:
- To survey the fundamental science of RIT.
- To review monoclonal antibodies and radionuclides employed in RIT.
- To examine the clinical applications and future directions of RIT.
Main Methods:
- Review of basic RIT science.
- Survey of monoclonal antibodies and radionuclides.
- Literature review of clinical RIT applications.
Main Results:
- RIT is an established oncologic therapeutic modality.
- Non-Hodgkin's lymphoma is a key area of RIT efficacy.
- New research indicates potential for hematological and solid-organ RIT.
Conclusions:
- RIT shows significant promise in oncology.
- Further development in radionuclides and clinical protocols is anticipated.
- RIT holds potential for expanded therapeutic applications.

